X-group (possible homology)

3921 Na(+)-translocating NADH-quinone reductase subunit D

Ligands and drugs

462
Member domains
78
with ligand contacts (≤ 4 Å)
16.9% of members
36
with DrugDomain annotations
7.8% of members
13
with a DrugBank compound
2.8% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

8
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Lipids and lipid-like molecules50.95.69×not tested
Nucleosides, nucleotides, and analogues42.21.83×not tested
Organic acids and derivatives21.21.64×not tested
Homogeneous metal compounds33.90.78×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03247FMNFlavin mononucleotide12
DB00123LYSLysine2
DB04327PEEPhosphatidylethanolamine1

Most frequently bound compounds

PDB ligandNameDomains in contact
FESFE2/S2 (INORGANIC) CLUSTER76
3PE1,2-Distearoyl-sn-glycerophosphoethanolamine12
FMNFLAVIN MONONUCLEOTIDE10
NAmetalSODIUM ION6
PTYPHOSPHATIDYLETHANOLAMINE6
CAmetalCALCIUM ION2
FEmetalFE (III) ION2
LYSLYSINE2
PEE1,2-dioleoyl-sn-glycero-3-phosphoethanolamine2